{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:04:54Z","timestamp":1759341894202},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.lpm.2012.05.031","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T04:32:39Z","timestamp":1357705959000},"page":"187-196","source":"Crossref","is-referenced-by-count":6,"title":["Anticoagulation du sujet \u00e2g\u00e9\u00a0: nouveaut\u00e9s th\u00e9rapeutiques"],"prefix":"10.1016","volume":"42","author":[{"given":"Carmelo","family":"Lafuente-Lafuente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Pautas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00ebl","family":"Belmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2012.05.031_bib0005","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","article-title":"Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres","volume":"320","author":"Pouyanne","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2012.05.031_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00002512-200623010-00002","article-title":"Haemorragic complications of vitamin K antagonists in the elderly: risk factors and management","volume":"23","author":"Pautas","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1016\/j.lpm.2012.05.031_bib0015","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2012.05.031_bib0020","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the national registry of atrial fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.lpm.2012.05.031_bib0025","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1378\/chest.130.5.1390","article-title":"Development of a contemporary bleeding risk model for elderly warfarin recipients","volume":"130","author":"Shireman","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2012.05.031_bib0030","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11319540-000000000-00000","article-title":"Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study","volume":"27","author":"Tulner","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.lpm.2012.05.031_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2012.05.031_bib0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0050","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.320.7244.1236","article-title":"Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness","volume":"320","author":"Kalra","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2012.05.031_bib0055","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2012.05.031_bib0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ageing\/afi004","article-title":"Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study","volume":"34","author":"Tsivgoulis","year":"2005","journal-title":"Age Ageing"},{"key":"10.1016\/j.lpm.2012.05.031_bib0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1532-5415.2005.53215.x","article-title":"People aged over 75\u00a0in atrial fibrillation on warfarin: the rate of major hemorrhage and stroke in more than 500\u00a0patient-years of follow-up","volume":"53","author":"Johnson","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.lpm.2012.05.031_bib0070","doi-asserted-by":"crossref","unstructured":"Guidelines for the management of atrial fibrillation: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369\u2013429.","DOI":"10.1093\/eurheartj\/ehq278"},{"key":"10.1016\/j.lpm.2012.05.031_bib0075","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1001\/archinte.164.18.2044","article-title":"Safety of anticoagulation therapy in well informed older patients","volume":"164","author":"Kagansky","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0080","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjmed.2005.02.022","article-title":"Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall","volume":"118","author":"Gage","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa0801748","article-title":"Effect of dissemination of evidence in reducing injuries from fails","volume":"359","author":"Tinetti","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0095","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.amjmed.2004.07.053","article-title":"Initiation of warfarin in elderly medical inpatients: a safe and accurate regimen","volume":"118","author":"Siguret","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1532-5415.2009.02675.x","article-title":"Improving anticoagulation control in hospitalized elderly patients on warfarin","volume":"58","author":"Gouin-Thibault","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.lpm.2012.05.031_bib0110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1046\/j.1365-2141.2003.04110.x","article-title":"Oral anticoagulants in the elderly","volume":"120","author":"Froom","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2012.05.031_bib0115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.amjmed.2006.07.045","article-title":"The safety of warfarin therapy in the nursing home setting","volume":"120","author":"Gurwitz","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/CIRCULATIONAHA.110.007864","article-title":"Bleeding risk in very old patients on vitamin K antagonist treatment","volume":"124","author":"Poli","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2012.05.031_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood-2009-09-241851","article-title":"The new oral anticoagulants","volume":"115","author":"Garcia","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2012.05.031_bib0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pharmthera.2010.12.007","article-title":"The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism","volume":"130","author":"Mavrakanas","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.lpm.2012.05.031_bib0135","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate \u2013 a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity","volume":"103","author":"van Ryn","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2012.05.031_bib0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003088-200847010-00005","article-title":"Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects","volume":"47","author":"Stangier","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.lpm.2012.05.031_bib0145","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood.V108.11.905.905","article-title":"The effect of extreme age, and gender, on the pharmacology and tolerability of rivaroxaban: an oral, direct factor Xa inhibitor [abstract no 905]","volume":"108","author":"Kubitza","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2012.05.031_bib0150","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/11595320-000000000-00000","article-title":"Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention","volume":"50","author":"Mueck","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.lpm.2012.05.031_bib0155","first-page":"455","article-title":"Effects of age and gender on the single-dose pharmacokinetics (PK) and pharmacodynamics (PD) of apixaban (abstract PP-MO-407)","volume":"7","author":"Frost","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2012.05.031_bib0160","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"RE-COVER Study Group","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0165","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Investigators","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0170","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Steering Committee","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0175","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation","volume":"365","author":"ROCKET AF Investigators","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0180","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"ARISTOTLE Committees and Investigators","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0185","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","author":"ATLAS ACS 2\u2013TIMI 51\u00a0Investigators","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0190","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1105819","article-title":"Apixaban with antiplatelet therapy after acute coronary syndrome","volume":"365","author":"APPRAISE-2\u00a0Investigators","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0195","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/j.1532-5415.2009.02385.x","article-title":"Renal function in older hospital patients is more accurately estimated using the Cockcroft-Gault formula than the modification diet in renal disease formula","volume":"57","author":"P\u00e9quignot","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.lpm.2012.05.031_bib0200","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2\u00a0doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) Trial","volume":"123","author":"Eikelboom","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2012.05.031_bib0205","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archinternmed.2011.314","article-title":"The use of dabigatran in elderly patients","volume":"171","author":"Legrand","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2012.05.031_bib0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","article-title":"Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED score","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498212006276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498212006276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T02:23:51Z","timestamp":1595211831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498212006276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0755498212006276"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2012.05.031","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}